Arcus Biosciences, Inc. (RCUS)
23.87
+0.13
(+0.55%)
USD |
NYSE |
May 21, 16:00
23.92
+0.04
(+0.19%)
After-Hours: 19:59
Arcus Biosciences Total Liabilities (Quarterly) : 473.00M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 32.85B |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Amgen, Inc. | 83.31B |
| Catalyst Pharmaceuticals, Inc. | 134.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 997.00M |
| Shareholders Equity (Quarterly) | 524.00M |
| Debt to Equity Ratio | 0.2156 |
| Current Ratio | 4.038 |
| Net Debt Paydown Yield | 0.34% |